CastleKeep Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Sell
4,313
-309
-7% -$72K 0.55% 35
2026
Q1
$1.13M Sell
4,622
-469
-9% -$109K 0.61% 31
2025
Q4
$1.05M Sell
5,091
-386
-7% -$76.3K 0.48% 56
2025
Q3
$1.02M Sell
5,477
-2,173
-28% -$372K 0.48% 58
2025
Q2
$1.17M Sell
7,650
-469
-6% -$72.1K 0.57% 66
2025
Q1
$1.35M Buy
8,119
+272
+3% +$42.6K 0.69% 45
2024
Q4
$1.13M Buy
7,847
+481
+7% +$74.5K 0.79% 54
2024
Q3
$1.19M Buy
7,366
+673
+10% +$107K 0.81% 41
2024
Q2
$978K Sell
6,693
-19
-0.3% -$2.83K 0.75% 41
2024
Q1
$1.06M Sell
6,712
-11,833
-64% -$1.88M 0.76% 39
2023
Q4
$2.91M Buy
+18,545
New +$2.84M 2.06% 9

Other funds holding JNJ

CastleKeep Investment Advisors's JNJ Position: Q2 2026 in Review

CastleKeep Investment Advisors reduced its Johnson & Johnson (JNJ) stake by 6.7% in Q2 2026, selling an estimated $72K and leaving 4,313 shares worth $1.1M. The position accounts for 0.55% of the portfolio, ranked #35.

CastleKeep Investment Advisors first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.91M in Q4 2023. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • CastleKeep Investment Advisors held 4,313 shares of Johnson & Johnson worth $1.1M as of Q2 2026.
  • CastleKeep Investment Advisors sold 309 Johnson & Johnson shares in Q2 2026, an estimated $72K.
  • Johnson & Johnson made up 0.55% of CastleKeep Investment Advisors's portfolio in Q2 2026, its #35 holding.
  • CastleKeep Investment Advisors first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • CastleKeep Investment Advisors's Johnson & Johnson position peaked at $2.91M in Q4 2023.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on CastleKeep Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.